This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
What You Should Know: – Sware , the leading provider of comprehensive GxP validation solutions for innovative lifesciences and technology companies, today announced that it will deliver GxP computer systems validation of Salesforce LifeSciences Cloud.
to deliver a comprehensive platform of software solutions for the lifesciences industry. Honeywell’s TrackWise Quality: Proactive Quality Management TrackWise Quality enables lifesciences companies to transition from reactive to proactive quality management by building a comprehensive quality ecosystem. ”
What You Should Know: – Salesforce announced the general availability of LifeSciences Cloud , a platform for pharmaceutical ( pharma ) and medicaltechnology ( medtech ) organizations to help personalize patient and healthcare professional (HCP) engagement and streamline clinical operations with data, automation, and trusted AI.
For wonky-tech readers, this involves using Seqster’s proprietary technology (FHIR+) to enable the flow of patient information from once-siloed data locked into legacy systems and wearable tech clouds.
With this in mind, it is critical that both payers and providers in VBC arrangements consider how their data flows through the entire system so that key partners, such as lifesciences and pharmaceutical companies – have real-world insights (RWI) about the impact their medication is having on outcomes.
These inconsistencies and inaccuracies tend to compound in medical device and medicaltechnology organizations where product portfolios are continually evolving, pricing fluctuates and quotes have to be configured to meet the specifications of each customer. But there are also some precautions to take with CPQ software.
That a pharmaceutical company executive is speaking on the main stage at CES speaks to digital health’s mainstreaming beyond elite athletes and smartwatches that track activity.
What You Should Know: – Model N (NYSE: MODN), a leading provider of revenue optimization and compliance solutions for the lifesciences and high-tech industries, has announced a definitive agreement to be acquired by Vista Equity Partners (“Vista”). per share in an all-cash transaction valued at approximately $1.25
To innovate more, and more quickly, across the entire ecosystem of health — in government policies, pharmaceutical innovations, and technology developments. To scale what works, based on evidence and proven interventions — which depends on our reducing biases in our assumptions, models and strategies.
The company is offering a hearing device integrating deep neural network technology that offers “BrainHearing through the ear” in a customized hearing aid. Last year, Abbott made a big splash with the company’s Board Chairman/CEO delivering a keynote addressing connected care. Among many other developments, I’ll be digging into….
Some policymakers have called for weakening of intellectual property protections for vaccines and other pharmaceutical products, with the aim to reduce the price and improve access to existing medicaltechnologies, particularly in Eastern Europe and developing countries. The abstract is below.
In the context of this fast-moving political debate, FTI Consulting supported INTERPAT, a non-profit biopharmaceutical consortium, and the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) in developing a White Paper and peer-reviewed article on the role of IP in the biopharmaceutical sector.
The disclosure of the genetic code went a long way to pinpointing the origins and the spread of the disease, and also to pharmaceutical targets for drug development. About Ivor Campbell Ivor Campbell is the CEO of Snedden Campbell , a UK-based recruitment agency for the global medicaltechnology industry.
Key investors Deerfield Management, Foresite Capital and Medical Excellence Capital remain committed to supporting the next phase of the companys growth strategy. Dr. Vaz Bio/Background Dr. Vaz an actively licensed physician with training and experience from prestigious institutions like Harvard Medical School and the University of Miami.
We organize all of the trending information in your field so you don't have to. Join 19,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content